Literature DB >> 2318526

Cloning and expression of functional fragment C of tetanus toxin.

J L Halpern1, W H Habig, E A Neale, S Stibitz.   

Abstract

A segment of Clostridium tetani DNA corresponding to fragment C of tetanus toxin was amplified by using the polymerase chain reaction. This fragment was cloned into expression vector pTTQ8, under the control of the tac promoter. Expression of this plasmid in Escherichia coli resulted in the production of a protein consisting of 8 amino acids of the vector fused to the C-terminal 460 amino acids of tetanus toxin. This protein (rFragment C) was recognized by an antipeptide antibody specific for fragment C in an enzyme-linked immunosorbent assay and on immunoblots. rFragment C could be purified significantly in one step by immunoaffinity chromatography. Immunization of mice with rFragment C resulted in the production of antibodies that were able to protect the mice against a challenge with tetanus toxin. rFragment C bound to ganglioside GT1b and to neuronal cells in a manner indistinguishable from that of fragment C obtained by papain cleavage of tetanus toxin. For many applications, rFragment C appears to be a suitable alternative to tetanus toxin or toxin-derived fragment C.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2318526      PMCID: PMC258574          DOI: 10.1128/iai.58.4.1004-1009.1990

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  29 in total

1.  Tetanus toxin: biochemical and pharmacological comparison between its protoxin and some isotoxins obtained by limited proteolysis.

Authors:  U Weller; F Mauler; E Habermann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-08       Impact factor: 3.000

2.  The complete nucleotide sequence of tetanus toxin.

Authors:  N F Fairweather; V A Lyness
Journal:  Nucleic Acids Res       Date:  1986-10-10       Impact factor: 16.971

Review 3.  Clostridial neurotoxins: handling and action at the cellular and molecular level.

Authors:  E Habermann; F Dreyer
Journal:  Curr Top Microbiol Immunol       Date:  1986       Impact factor: 4.291

4.  The structural gene for tetanus neurotoxin is on a plasmid.

Authors:  C W Finn; R P Silver; W H Habig; M C Hardegree; G Zon; C F Garon
Journal:  Science       Date:  1984-05-25       Impact factor: 47.728

5.  Multicopy expression vectors carrying the lac repressor gene for regulated high-level expression of genes in Escherichia coli.

Authors:  M J Stark
Journal:  Gene       Date:  1987       Impact factor: 3.688

6.  Immunization of mice against tetanus with fragments of tetanus toxin synthesized in Escherichia coli.

Authors:  N F Fairweather; V A Lyness; D J Maskell
Journal:  Infect Immun       Date:  1987-11       Impact factor: 3.441

7.  Intracellularly injected tetanus toxin inhibits exocytosis in bovine adrenal chromaffin cells.

Authors:  R Penner; E Neher; F Dreyer
Journal:  Nature       Date:  1986 Nov 6-12       Impact factor: 49.962

8.  Monoclonal antibodies as probes of tetanus toxin structure and function.

Authors:  J G Kenimer; W H Habig; M C Hardegree
Journal:  Infect Immun       Date:  1983-12       Impact factor: 3.441

9.  Automated synthesis and use of N-chloroacetyl-modified peptides for the preparation of synthetic peptide polymers and peptide-protein immunogens.

Authors:  W Lindner; F A Robey
Journal:  Int J Pept Protein Res       Date:  1987-12

10.  Tetanus toxin: primary structure, expression in E. coli, and homology with botulinum toxins.

Authors:  U Eisel; W Jarausch; K Goretzki; A Henschen; J Engels; U Weller; M Hudel; E Habermann; H Niemann
Journal:  EMBO J       Date:  1986-10       Impact factor: 11.598

View more
  16 in total

1.  Dual antigenic recognition by cloned human gamma delta T cells.

Authors:  J Holoshitz; L M Vila; B J Keroack; D R McKinley; N K Bayne
Journal:  J Clin Invest       Date:  1992-01       Impact factor: 14.808

2.  Neuronal lysosomal enzyme replacement using fragment C of tetanus toxin.

Authors:  K Dobrenis; A Joseph; M C Rattazzi
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-15       Impact factor: 11.205

3.  Synthesis of tetanus toxin fragment C in insect cells by use of a baculovirus expression system.

Authors:  I G Charles; B C Rodgers; A J Makoff; S N Chatfield; D E Slater; N F Fairweather
Journal:  Infect Immun       Date:  1991-05       Impact factor: 3.441

Review 4.  Properties and use of botulinum toxin and other microbial neurotoxins in medicine.

Authors:  E J Schantz; E A Johnson
Journal:  Microbiol Rev       Date:  1992-03

5.  Cell surface-exposed tetanus toxin fragment C produced by recombinant Bacillus anthracis protects against tetanus toxin.

Authors:  S Mesnage; M Weber-Levy; M Haustant; M Mock; A Fouet
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

6.  Neutralizing antibodies and immunoprotection against pertussis and tetanus obtained by use of a recombinant pertussis toxin-tetanus toxin fusion protein.

Authors:  P Boucher; H Sato; Y Sato; C Locht
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

7.  Construction of hybrid proteins that migrate retrogradely and transynaptically into the central nervous system.

Authors:  L Coen; R Osta; M Maury; P Brûlet
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

8.  Heterogeneity of subcellular localization and electrophoretic mobility of survival motor neuron (SMN) protein in mammalian neural cells and tissues.

Authors:  J W Francis; A W Sandrock; P G Bhide; J P Vonsattel; R H Brown
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

9.  Expression and immunogenicity of pertussis toxin S1 subunit-tetanus toxin fragment C fusions in Salmonella typhi vaccine strain CVD 908.

Authors:  E M Barry; O Gomez-Duarte; S Chatfield; R Rappuoli; M Pizza; G Losonsky; J Galen; M M Levine
Journal:  Infect Immun       Date:  1996-10       Impact factor: 3.441

10.  Fragment C of tetanus toxin, more than a carrier. Novel perspectives in non-viral ALS gene therapy.

Authors:  María Moreno-Igoa; Ana Cristina Calvo; Clara Penas; Raquel Manzano; Sara Oliván; María Jesús Muñoz; Renzo Mancuso; Pilar Zaragoza; José Aguilera; Xavier Navarro; Rosario Osta Pinzolas
Journal:  J Mol Med (Berl)       Date:  2010-03       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.